MedApp S.A. has strengthened its cooperation with NEO Hospital Group. As part of the signed agreement, the Group’s Szpital na Klinach will use the CarnaLife Holo technology for 3D visualization of imaged medical data in the implementation of a newresearch and development project. Its goal is to develop a new method for the surgical treatment of endometrial and cervical cancers.
“The coronavirus pandemic has drastically affected the implementation of prevention programs. Diagnostics have also suffered greatly. We will emerge from the pandemic with an alarming scale of health debt. We must look for methods and tools to improve the effectiveness of treatment of oncology patients. Our research program, based on minimally invasive therapeutic methods, modern equipment and innovative systems supporting the process of treatment planning, creates such an opportunity for women with cervical and endometrial cancer,” says Joanna Szyman, CEO of NEO Hospital Group.
The CarnaLife Holo solution will be used by NEO Hospital in a project concerning surgical treatment of cervical and endometrial cancer. The surgeries will be performed at Szpital na Klinach in Kraków under funding from the Malopolska Regional Operational Program for 2014 -2020. Under the project, the Hospital will perform 200 procedures using the DaVinci robot. The treatment will be free of charge for the patients.
“CarnaLife Holo streamlines diagnostic processes, which, especially in difficult and complex procedures, can impact the physician’s precision and safety. We are pleased that our innovations are increasingly used in daily medical practice, supporting medics during surgical procedures,” says Krzysztof Mędrala, CEO of MedApp.
Read more See similar articles:
The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.
In connection with the publication of the Interim Report for Q2 2021 on September 12, 2021, we invite you to watch the interview with Krzysztof Mędrala, CEO of MedApp S.A. according to Company’s activities realized in the reporting period and the financial results achieved in H1 2021.
MedApp significantly increases its business scale in Q2 2021.
The Cracow-based company, offering innovative technological solutions in medicine (medtech), achieved a net result in the first half of this year, similar to the level for the whole of last year.